These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9064131)

  • 1. [Use of dalargin in the treatment of acute cholecystopancreatitis complicated by obstructive jaundice].
    Skomarovskiĭ ATs; Zemskov VS; Skomarovskiĭ AA
    Klin Khir; 1996; (8):13-4. PubMed ID: 9064131
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapy of patients with chronic pancreatitis of alcoholic etiology by dalagrin and laser therapy of the blood].
    Bulychev VF; Vakhrushev IaM
    Klin Med (Mosk); 2000; 78(12):43-6. PubMed ID: 11210353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The use of dalargin for treating recurrent aphthous stomatitis].
    Maksimovskaia LN
    Stomatologiia (Mosk); 1995; 74(4):15. PubMed ID: 7502297
    [No Abstract]   [Full Text] [Related]  

  • 4. [The use of trasylol in the treatment of acute pancreatitis and cholecystopancreatitis].
    Popova LN
    Vestn Khir Im I I Grek; 1969 Feb; 102(2):31-4. PubMed ID: 5306268
    [No Abstract]   [Full Text] [Related]  

  • 5. [Application of synthetic neuropeptides in complex of surgical treatment of acute pancreatitis and its complication].
    Pobuts'kyĭ OO
    Klin Khir; 2002 Jan; (1):26-9. PubMed ID: 11944292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [On the treatment of pancreatitis and cholecystopancreatitis with trasylol].
    Mavrodi VM
    Vestn Khir Im I I Grek; 1968 May; 100(5):41-3. PubMed ID: 5301803
    [No Abstract]   [Full Text] [Related]  

  • 7. [Dalargin in the therapy of the exacerbations of chronic pancreatitis].
    Geller LI; Kazakevich VV; Pashko MM
    Ter Arkh; 1992; 64(8):80-2. PubMed ID: 1279830
    [No Abstract]   [Full Text] [Related]  

  • 8. [Morphofunctional changes in the pancreas in response to dalargin under normal conditions and in experimental pancreatitis].
    Kurzanov AN; Titova GP; Vinogradov VA; Aleĭnik VA; Gerasimov NF
    Biull Eksp Biol Med; 1988 Apr; 105(4):445-7. PubMed ID: 3359026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnosis and treatment of acute cholecystopancreatitis complicated by obstructive jaundice].
    Prikupets VL; Artem'eva NG
    Sov Med; 1990; (11):94-8. PubMed ID: 2075533
    [No Abstract]   [Full Text] [Related]  

  • 10. [Dalargin--the first enkephalin analog, used in gastroenterology].
    Vinogradov VA; Polonskiĭ VM
    Ter Arkh; 1988; 60(8):147-53. PubMed ID: 3067406
    [No Abstract]   [Full Text] [Related]  

  • 11. [The antioxidant action of dalargin on the liver in experimental acute cholestasis].
    Korotkina RN; Fomchenkov EP; Babkina NV; Andreev VI; Shloznikov BM; Karelin AA
    Patol Fiziol Eksp Ter; 1990; (4):42-4. PubMed ID: 2080086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of dalargin as a component of postoperative analgesia in middle-aged and aged persons].
    Malyshev VD; Slastnikov SV; Sviridov SV; Bocharov VA; Mel'nik OB; Kasimov AO
    Anesteziol Reanimatol; 1995; (1):66-8. PubMed ID: 7605044
    [No Abstract]   [Full Text] [Related]  

  • 13. [Dalargin in the prevention of acute postoperative pancreatitis].
    Grigorevskiĭ VP; Korotkina RN; Pomelov VS; Shloznikov BM; Karelin AA
    Klin Khir (1962); 1989; (11):9-12. PubMed ID: 2640568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The clinico-laboratory assessment of the efficacy of dalargin in treating acute suppurative-inflammatory processes of the maxillofacial area].
    Bazhanov NN; Ganina SS; Pashutin SB; Ragimov ChR
    Sov Med; 1991; (7):29-31. PubMed ID: 1948337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Endonasal electrophoresis of dalargin in the therapy of multiple and giant duodenal ulcers].
    Buglak NP; Kostiukova EA; Asanova LK; Moshko IuA
    Lik Sprava; 2003 Dec; (8):102-3. PubMed ID: 14965021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [On the antienzyme therapy of acute cholecystopancreatitis].
    Shabanov AN; Shaternikov VA; Titov RI
    Khirurgiia (Mosk); 1967 Sep; 43(9):75-9. PubMed ID: 5304934
    [No Abstract]   [Full Text] [Related]  

  • 17. [Use of epsilon-aminocaproic acid (EACA) in acute pancreatitis and cholecystopancreatitis].
    Bkhatta AD
    Klin Khir (1962); 1973 Nov; 11():52-5. PubMed ID: 4788526
    [No Abstract]   [Full Text] [Related]  

  • 18. [Transcranial electrostimulation combined with dalargin ultraphonophoresis in the treatment of patients with chronic idiopathic eczema].
    Iakushkina NIu; Silina LV; Zav'ialov AV
    Vopr Kurortol Fizioter Lech Fiz Kult; 2005; (4):25-7. PubMed ID: 16149414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of oral dalargin-loaded nanoparticle delivery across the blood-brain barrier.
    Schroeder U; Sommerfeld P; Sabel BA
    Peptides; 1998; 19(4):777-80. PubMed ID: 9622035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of synthetic analogs of L-enkephalin on viable areas of the pancreas in experimental pancreatitis].
    Kanaian AS; Permiakov NK; Titova GP; Gabrielian NA; Voskanian LO
    Biull Eksp Biol Med; 1988 Apr; 105(4):447-51. PubMed ID: 3359027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.